“We have already started making improvements and we are fully committed to making the necessary short- and long-term enhancements to meet or exceed FDA’s standards,” the company said Tuesday. Johnson & Johnson, which has taken over production oversight at the Emergent plant, provided no details but said it is continuing to “partner closely” with the U.S. government on the facility.

Source: Washington Post May 13, 2021 18:29 UTC